QNRX News and Press, Quoin Pharmaceuticals Ltd. From 07/01/22

Penny Stocks To Buy Now? 3 To Watch Penny stocks are shares of companies trading below $5, but that’s still too expensive for some. This week’s trend of popular stocks under $1 continued on Friday. Earlier in the week, we saw companies like Evofem (NASDAQ: EVFM ) and B...

Unofficial sources said Joincare would seek to raise around $300 to $400 million. META Pharma of Shenzhen raised $15 million in Seed and Pre-A rounds to fund its immunometabolism-based small-molecule drug discovery operations. CANbridge, a Beijing-Cambridge MA rare disease/rare on...

Quoin Pharmaceuticals (NASDAQ:QNRX) on Wednesday said that on June 10 it had got a notification from Nasdaq that the company was not in compliance with a listing rule on minimum bid price requirement. The company has 180 days, or until Dec. 7, to regain compliance. QNRX earlier in the day sai...

ASHBURN, Va., June 15, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that the Company received a written notification (the "No...

Quoin Pharmaceuticals (NASDAQ:QNRX) on Wednesday said it had secured a licensing and distribution agreement with China-based Hong Kong WinHealth Pharma Group for two of QNRX's product candidates. The agreement is for QNRX's lead product candidate QRX003 for the treatment of Netherton syndrome...

ASHBURN, Va., June 15, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced it has secured a license and distribution agreement with ...

Penny stocks are great tools to make money in the stock market. While they don’t come without risk, there are plenty of ways to ensure you find the top names to watch. One of the first steps is looking for specific catalysts. These could be anything from unusual trading activity to m...

LAS VEGAS, NV / ACCESSWIRE / June 6, 2022 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI), is pleased to announce that its licensee Quoin Pharmaceuticals, Inc. ("Quoin") (NASDAQ:QNRX), has received U.S. FDA acceptance of its Investigational New Drug (IND) application for its licensed formul...

ASHBURN, Va., May 23, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced it has signed a second, exclusive research agreement with ...

Quoin Pharmaceuticals (QNRX) is developing a potential treatment for a patient population in desperate need. We spoke with CEO, Dr. Michael Myers, to find out more about Netherton Syndrome, a rare and devastating genetic disease. New York, New York--(Newsfile Corp. - May 17, 2022) - PCG Digi...